Shrimp aquaculture faces significant disease challenges from pathogens causing mass mortality and welfare concerns, with prevention strategies reducing both welfare harm and production loss.
Shrimp disease welfare involves the suffering of billions of animals during disease progression and mass mortality events. Disease prevention through biosecurity and probiotics simultaneously improves welfare and reduces production losses, creating aligned incentives for adoption. Genetic resistance programs represent a long-term solution that reduces welfare harm through improved individual resilience.